News
Media
All VideosMedical World NewsPodcastsWeekly RecapCure ConnectionsInsightsSpecial ReportNeurologyLive Peer ExchangeMedcastPeers & PerspectivesRoundtable Discussions
Conferences
Conference CoverageConference Listing
CME/CE
More
Partners
Publications
NeurologyLiveBridging the GapsInternational Journal of MS Care
Resources
Expert AuthorsFDA NewsFeaturesFellows' CornerFuture Leaders in NeurologyGiants of Multiple SclerosisInteractive ToolsJob BoardLive EventsNeurology ResourcesSponsoredVirtual Events

Subscribe

  • News
  • Media
  • Conferences
  • CME/CE
  • Partners
  • Publications
  • Resources
  • Subscribe
  • Dementia and Alzheimer Disease
  • Epilepsy
  • Genetic Disorders
  • Headache and Migraine
    • Migraine
  • MS and Demyelinating Disorders
    • NMOSD
    • Multiple Sclerosis
    • MS Advanced Practice Providers
  • Movement Disorders
    • Parkinson Disease
  • Neuromuscular
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Muscular Dystrophy
    • Ataxia
  • Rare Diseases
  • Sleep Disorders
    • Narcolepsy
    • Insomnia
  • Stroke
Spotlight -
Expert Authors|
FDA News|
ECTRIMS 2025|
MDS 2025
Advertisement

Advances in Early Treatment Approaches in Multiple Sclerosis

EP. 1: Updated McDonald Criteria for Diagnosing MS

February 14th 2020

EP. 2: Diagnostic Work-Up for MS

February 14th 2020

EP. 3: MRI in the Diagnosis of MS

February 14th 2020

EP. 4: Clinical Courses in MS

February 14th 2020

EP. 5: Modern Conversion Rate to Secondary MS

February 14th 2020

EP. 6: Importance of Early Treatment of MS

February 14th 2020

EP. 7: Choosing Initial Therapy for Treatment of MS

February 14th 2020

EP. 8: Factors to Consider for First-Line Therapy for MS

February 14th 2020

EP. 9: Recent Treatment Strategies Explored for Relapsing MS

February 14th 2020

EP. 10: ASSESS Clinical Trial of Fingolimod for Treatment of MS

February 14th 2020

EP. 11: Rebound Management Strategies for MS Therapies

February 14th 2020

EP. 12: EXPAND Clinical Trial of Siponimod for Treatment of MS

February 14th 2020

EP. 13: Patient Selection for Alemtuzumab for Treatment of MS

February 14th 2020

EP. 14: Recent Approvals for MS: Cladribine and Diroximel Fumarate

February 14th 2020

EP. 15: Review of Natalizumab for MS

February 14th 2020

EP. 16: Original Drugs to Treat MS

February 14th 2020

EP. 17: Drugs in Development for MS, Including Ofatumumab

February 14th 2020

EP. 18: Unmet Needs and Final Thoughts on Treating MS

February 14th 2020
Advertisement
Advertisement

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

1

NLRP3 Inhibitor VTX3232 Well Tolerated, Improves Parkinson Symptoms in Phase 2a Trial

2

Exploring the Role of Aerobic Exercise in Promoting Remyelination in Multiple Sclerosis: Lindsey Wooliscroft, MD, MS

3

Bilateral MR-Guided Focused Ultrasound Shows Benefit for Managing Parkinson Motor Complications in Phase 3 Trial

4

Ruptured vs Unruptured Aneurysms: Practical Decision Making with Guilherme Dabus, MD

5

NeurologyLive® Friday 5 — October 17, 2025

  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us